Venter’s New Digs

Genomics pioneer Craig Venter is building a new campus for his non-profit research institute right next to his alma mater in San Diego.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, VIA PLOS ONEGenomicist and entrepreneur Craig Venter is erecting a $37-million, 45,000-square-foot building nestled in the University of California, San Diego, campus and near the Salk Institute in La Jolla, California. The building, which is expected to open on November 9, will be a satellite campus for his Rockville, MD-based J. Craig Venter Institute and will house 125 scientists and staff, according to the San Diego Union Tribune. “I wanted a special property that went with the special nature of the institute and, if possible, to be overlooking the ocean,” Venter told the Union Tribune.

The latest addition to the vibrant life science hub in San Diego has Venter’s neighbors pretty excited. “Craig is an extremely creative guy,” Michael Marletta, CEO of The Scripps Research Institute, told the Union Tribune. “He pushes the envelope beyond what people thought, he has provocative ideas, [and] he acts on those ideas. So to have him here is a big plus for us.”

Larry Goldstein, a UC San Diego stem cell researcher who has collaborated with Venter, shared Marletta’s enthusiasm. “When you bring a guy of his energy and creativity permanently into our community, he’s going to create value,” he said. “He’s going to create new areas that we’re going to investigate scientifically.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies